Manufacturing

Pharmaceutical Outsourcing Manufacturing

Contract development and manufacturing companies, or CDMOs, provide a wide range of drug development, formulation and manufacturing services to companies that need outsourcing help to bring pharmaceutical products to market.

Full-service contract development and manufacturing companies can take on every aspect of drug development and manufacturing – many can develop a variety of dosage forms. Specialized CDMOs typically concentrate on one kind of dosage form.

Services offered by contract manufacturing organizations typically include, but are not limited to:

Formulation
Analytical Services
Blending
Coating
Tableting
Parenteral Product R&D and Manufacturing
Aseptic Filling
Unit Dose Semi-Solids

Transdermal Product Development and Manufacturing
Topicals
Converting
Packaging
Serialization
Shipment

Filter

Hide Filter

10x Genomics Signs Patent Agreement with Bio-Rad
Tuesday, July 27, 2021
10x Genomics Inc. announced that it has entered into a global settlement and cross-license agreement with Bio-Rad Laboratories Inc.. The agreement grants each company a non-exclusive, worldwide, royalty-bearing license to develop products and ... read more
Catalent Launches New OptiDose® Design Solution
Tuesday, July 27, 2021
Catalent’s OptiDose Design Solution, led by Catalent’s scientific advisors, uses a design approach that combines data-driven scientific tools with Catalent’s extensive development expertise. Integrating pharmaceutics, and dose form design target ... read more
Genezen Appoints Vice President of Operations
Tuesday, July 27, 2021
Genezen Laboratories Inc. a cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has further strengthened its senior leadership team with the appointment of Brok Weichbrodt as Vice President of Operations. read more
Vetter’s New Clinical Manufacturing Site Fully Integrated
Thursday, July 22, 2021
Vetter, a leading global Contract Development and Manufacturing?Organization?(CDMO) has further?invested in additional?capacity to meet this growing global demand in Rankweil, Austria. The site has been modified to the high Vetter quality standards ... read more
SPT Labtech Announces Leadership Changes
Thursday, July 22, 2021
SPT Labtech, a laboratory automation solutions company for the life sciences industry, announced that David Newble has been appointed CEO, stepping up from his previous position as Managing Director. In his new capacity, he takes responsibility for ... read more
Archimica’s $1.4 Million Manufacturing Expansion
Thursday, July 22, 2021
Archimica has started the operation of its expanded multi-purpose manufacturing capacity at its Lodi (Italy) site. Recent investment has added significantly to the company´s capabilities overall 170 m3 highly flexible reactor capacity to realize API ... read more
Kineta and Samsung Biologics to Develop and Manufacture Antibody Immunotherapy
Thursday, July 22, 2021
Samsung Biologics signed a strategic partnership agreement with Kineta, Inc., a clinical-stage biotech company developing novel immunotherapies in oncology. Samsung Biologics will provide end-to-end CDMO service from cell line development, clinical ... read more
Catalent Biologics New Lightning Cell Line Expression Technology
Thursday, July 22, 2021
Catalent announced the launch of a next-generation cell line development technology, GPEx® Lightning. Leveraging Catalent’s proven GPEx expression platform in a glutamine synthase (GS) knock-out Chinese hamster ovary (CHO) cell line system, GPEx ... read more
Element acquires Arch Sciences Group
Thursday, July 22, 2021
Element Materials Technology has acquired Arch Sciences Group, a leading provider of analytical services and laboratory solutions in pharmaceuticals. As well as marking Element’s entry into the European pharmaceutical market, the move means that the ... read more
Catalent Plans Multi-Phase $100 Million Expansion of Biologics Manufacturing
Thursday, July 22, 2021
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that it will commence the first phase of a ... read more
Recro Appoints Inaugural Vice President of People, Culture and ESG
Thursday, July 22, 2021
Recro Pharma Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products announced the appointment of Erica Raether as... read more
Lonza Extends Collaboration for Monoclonal Antibody Supply at Scale
Friday, July 16, 2021
Lonza, a CDMO partner to the biopharma industry, announced the extension of its collaboration with a major biopharmaceutical partner for the commercial-scale manufacture of monoclonal antibodies, under a long-term agreement. At scale, and following ... read more
Thermo Fisher Scientific Opens Plasmid DNA Manufacturing Facility
Friday, July 16, 2021
Thermo Fisher Scientific Inc., has opened a new cGMP plasmid DNA manufacturing facility in Carlsbad, Calif., enabling it to meet the rapidly growing demand for plasmid DNA-based therapies and vital mRNA-based vaccines. read more
H.E.L Group Strengthens North American Operations
Thursday, July 15, 2021
H.E.L Group (H.E.L), a developer and manufacturer of laboratory tools for process optimization, safety, and scale-up, announced that it has expanded its operations in North America, with the establishment of a West Coast hub in California, and a ... read more
Recro Signs Development and Manufacturing Agreement with New Client
Thursday, July 15, 2021
Recro Pharma Inc, a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges for companies developing oral solid dose drug products, announced the signing of a development and ... read more